http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-933837-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
filingDate 1993-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e4005a230ce07baea78f7ab53a79d24
publicationDate 1993-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-933837-L
titleOfInvention 4-aryl-3- (heteroarylureido) quinoline derivatives
abstract Compounds of formula (I) and pharmaceutically acceptable salts thereof are described, wherein R 1, R 2, R 3, R 4, m, X and Q are as defined in the specification, and novel intermediates used in the synthesis of such compounds. The compounds of formula (I) are inhibitors of acyl-coenzyme A: cholesterol-acyltransferase and are useful as hypolipidemic and anti-aarosclerotic agents.
priorityDate 1991-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12623
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID855316
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID747009
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403643
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1066
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009551
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID512098
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID102129184
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29225

Total number of triples: 42.